Gsk Share Discussion Threads

[juju44] 15/2/2018 09:02

back in again . Techs still saying BUY

[bilster1] 15/2/2018 08:59

Hi Monty - when do you think this will be?

[montyhedge] 15/2/2018 08:49

Should be hearing about the bid shortly.

[abdullla] 14/2/2018 12:27

Thanks more the merrier,bring it on !

[montyhedge] 14/2/2018 12:26

Ah thats better, abdullla gone.

[montyhedge] 14/2/2018 12:25

abdulla
Make it a treble, your filtered by me, lol.

[abdullla] 14/2/2018 12:20

Yes thanks I do like my coffee FILTERED,two sugars please !

[romeike] 14/2/2018 11:58

abdullla14 Feb '18 - 10:41 - 16670 of 16672 (Filtered)
abdullla14 Feb '18 - 10:51 - 16671 of 16672 (Filtered)

[abdullla] 14/2/2018 10:51

Abdullla Filtered twice in one day,now that is a DOUBLE WHAMMY !But thanks for the medals .

[abdullla] 14/2/2018 10:41

Further more it will be a double whammy if GSK loses more than 23p from now to all the way upto next Thursday !

[montyhedge] 14/2/2018 10:40

Don't think it will drop 23p, I reckon 16p.

[abdullla] 14/2/2018 10:30

market is fearful of the oncoming ex-div date,the drop in share price at the open could be more then 23p,so buying after the evant could be quids-in,imo !

[montyhedge] 14/2/2018 08:22

Next quarterly div next Thursday, 23p in the bag, nice.

[dr biotech] 14/2/2018 08:13

Have to have some faith in EW as she was head of the consumer division and knows more about it than us.

Would be nice to see the share price perform at least inline with the wider market though..

[romeike] 13/2/2018 22:51

Perhaps, and yet they still have more support for their bid.

[toffeeman] 13/2/2018 16:59

I think RB. would get caned if they went for the Pfizer bits - so soon after Mead Johnson

[montyhedge] 13/2/2018 15:56

romeike
Sorry typed the wrong company, of course I mean Reckitt. lol

[romeike] 13/2/2018 14:12

Are we likely to hear more about GSK’916 single agent (Monotherapy for Multiple Myeloma) before trial results during 2019? 2020+ earnings could look very different from the current guidance if this treatment is as successful as trials to date suggest.

[romeike] 13/2/2018 14:10

@Monty - how can Unilever win when they didn't submit a bid ahead of the deadline? Worth noting RB has more to gain and more support from within to win with a bid that Pfizer might accept .

[toffeeman] 13/2/2018 13:36

Be amazed if Unilever bid

[montyhedge] 13/2/2018 12:43

If I had to bet, shareprices talk, looking at shareprices my guess Reckitt will win the Pfizer consumer division bid.

[abdullla] 13/2/2018 07:40

jrphoenixw2,NOT FILTERED !

[jrphoenixw2] 13/2/2018 07:33

abdulla - filtered

[ianood] 12/2/2018 16:12

abdulla - filtered

[romeike] 12/2/2018 15:00

GSK have stated they want to have 100% of the JV and have planned for it, but the ball is in Novartis court re: when this will happen. My understanding is that Novartis is currently benefiting rather well from the JV arrangement and is unlikely to exercise their option to sell any time soon.